China channel feed – Endpoints News

China channel feed

Lawmakers ask Biden administration to tighten rules around China clinical trials

4 months ago

Four biotechs emerge with $800M and in-licensed assets on Friday

4 months ago

Another biotech scoops up asset from China-based Keymed and nabs $180M

4 months ago

Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio

4 months ago

WuXi Biologics to sell Irish vaccine site to Merck for $500M

4 months ago

WuXi AppTec will sell cell and gene therapy business to private equity firm

4 months ago

Post-Hoc: Biosecure is dead. Long live Biosecure?

5 months ago

Merck’s long-awaited obesity move is an oral GLP-1 from China

5 months ago

The Endpoints 100: The biotech industry braces for Trump 2.0

5 months ago

Exclusive: Bain-backed musculoskeletal biotech raises $120M for trio of clinical-stage biologics

5 months ago

Biosecure bill is left out of end-of-year defense package, dealing blow to chances

5 months ago

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

5 months ago

Sanofi earmarks €1B for new insulin production factory in Beijing

5 months ago

Exclusive: Athena Countouriotis' Avenzo taps Shanghai biotech for ADC, adds new funds

6 months ago

BeiGene will rebrand to BeOne Medicines, dropping name's link to China roots

6 months ago

Merck buys into PD-1/VEGF space as Summit comes for Keytruda

6 months ago

New cancer class heats up as BioNTech buys out China partner and its PD-L1/VEGF drug

6 months ago

AstraZeneca CEO reaffirms commitment to China following executive's detention

6 months ago

Merck KGaA plans China submission after late-stage win for tumor drug

6 months ago

Pfizer to invest $1B in China over next five years — reports

6 months ago

Senior AstraZeneca exec detained in China amid wider investigation

6 months ago

Joe Jimenez's latest Aditum company lines up T cell engager from China

6 months ago

GSK CEO Emma Walmsley on the new Trump administration, trust, AI and China

6 months ago

Baxter pulls IV products out of China to shift supply to the US

6 months ago

First page Previous page 1 234 5 6 Next page Last page